Purchase Short-Term Access

Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial
James R. Seibold, MD; Joseph H. Korn, MD; Robert Simms, MD; Phillip J. Clements, MD, MPH; Larry W. Moreland, MD; Maureen D. Mayes, MD, MPH; Daniel E. Furst, MD; Naomi Rothfield, MD; Virginia Steen, MD; Michael Weisman, MD; David Collier, MD; Fredrick M. Wigley, MD; Peter A. Merkel, MD, MPH; Mary Ellen Csuka, MD; Vivien Hsu, MD; Susan Rocco, BS; Mark Erikson, BS; John Hannigan, MS; W. Scott Harkonen, MD; Martin E. Sanders, MD
Annals of Internal Medicine 2000;132:871-879. doi:10.7326/0003-4819-132-11-200006060-00004

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.